Jennifer L Good
Director; Director, President & CEO · 2 filings · Latest: Jun 23, 2026
RHYTHM PHARMACEUTICALS, INC.
Trevi Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RYTM | Jennifer L Good | Director | Jun 23, 2026 | Option Exercise | — | 4,712 | — | 11,712 | |
TRVI | GOOD JENNIFER L | — | Mar 21, 2025 | Proposed Sale | $6.58 | 5,263 | $34.6K | — | |
RYTM | JENNIFER GOOD | — | Sep 17, 2024 | Proposed Sale | $49.52 | 31,751 | $1.6M | — | |
RYTM | JENNIFER GOOD | — | Sep 9, 2024 | Proposed Sale | $49.25 | 16,749 | $824.9K | — | |
TRVI | GOOD JENNIFER L | — | Sep 3, 2024 | Proposed Sale | $3.16 | 61,180 | $193.3K | — | |
RYTM | JENNIFER GOOD | — | Aug 26, 2024 | Proposed Sale | $46.12 | 35,000 | $1.6M | — |